TABLE 2.
Comparison between simulated data and clinical data of the 14 HVAD patients of Group1: MAP, mean arterial pressure; RAP, right atrial pressure; PAPm, mean pulmonary arterial pressure; Pwedge, pulmonary capillary wedge pressure; CO, cardiac output; SatvO2 , mixed venous oxygen saturation; LVESV, end-diastolic left ventricular volume.
| HVAD flow | MAP | RAP | PAPm | Pwedge | CO | SatvO2 | LVEDV | ||
|---|---|---|---|---|---|---|---|---|---|
| L/min | mmHg | mmHg | mmHg | mmHg | L/min | % | mL | ||
| Clinical data | 4.6 ± 0.8 | 84 ± 8 | 9 ± 4 | 23 ± 6 | 15 ± 5 | 4.9 ± 1.1 | 63 ± 5 | 173 ± 77 | |
| Step 1—rest | Simulated data | 4.8 ± 0.0 | 88 ± 0 | 11 ± 1 | 26 ± 1 | 16 ± 1 | 4.8 ± 0.1 | 58 ± 0 | 181 ± 1 |
| %Error | 5.3 | 5.1 | 23.2 | 12.7 | 6.7 | −1.3 | −8.3 | 4.6 | |
| Clinical data | 5.9 ± 0.9 | 94 ± 9 | 17 ± 5 | 38 ± 8 | 30 ± 8 | 6.3 ± 1.5 | 27 ± 8 | 173 ± 77 | |
| Step 2—Group1 exe. (44 W) | Simulated data | 5.0 ± 0.0 | 93 ± 1 | 13 ± 2 | 31 ± 1 | 20 ± 2 | 6.0 ± 0.2 | 27 ± 0 | 190 ± 1 |
| %Error | −15.3 | −1.1 | −23.2 | −18.0 | −32.7 | −4.1 | 0.2 | 9.8 | |
| Clinical data | 6.7 ± 1.0 | 94 ± 8 | 18 ± 6 | 37 ± 8 | 27 ± 8 | 5.7 ± 1.1 | 27 ± 10 | 173 ± 77 | |
| Step 3—Group1 exe. (44 W) + increased HVAD speed | Simulated data | 6.1 ± 0.0 | 95 ± 1 | 13 ± 2 | 30 ± 1 | 18 ± 2 | 6.2 ± 0.1 | 28 ± 0 | 182 ± 1 |
| %Error | −8.9 | 1.5 | −26.8 | −18.1 | −33.2 | 9.1 | 5.0 | 5.2 |